Brent Pfeiffenberger Century Therapeutics, Inc. (IPSC) insider trading activity

Brent Pfeiffenberger is President and CEO of Century Therapeutics, Inc.. Currently has a direct ownership of 3.27 Million shares of IPSC, which is worth approximately $1.63 Million. The most recent transaction as insider was on Sep 08, 2025, when has been sold 488 shares (Common Stock) at a price of $0.5 per share, resulting in proceeds of $244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.27M

94.37% 3M change

122.27% 12M change

Total Value Held $1.63 Million

Brent Pfeiffenberger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2025	SELL Open market or private sale	$244 $0.5 p/Share	488 Reduced 0.01%	3,268,909 Common Stock
Aug 14 2025	BUY Grant, award, or other acquisition	-	1,587,614 Added 32.69%	3,269,397 Common Stock
Jun 09 2025	SELL Open market or private sale	$294 $0.62 p/Share	475 Reduced 0.03%	1,681,783 Common Stock
May 16 2025	SELL Open market or private sale	$16,253 $0.55 p/Share	29,552 Reduced 1.73%	1,682,258 Common Stock
Mar 11 2025	BUY Grant, award, or other acquisition	-	521,500 Added 23.35%	1,711,810 Common Stock
Mar 10 2025	SELL Open market or private sale	$1,385 $0.62 p/Share	2,235 Reduced 0.19%	1,190,310 Common Stock
Feb 18 2025	SELL Open market or private sale	$27,075 $0.78 p/Share	34,712 Reduced 2.83%	1,192,545 Common Stock
Dec 04 2024	SELL Payment of exercise price or tax liability	$350,563 $1.44 p/Share	243,447 Reduced 16.55%	1,227,257 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	17,425 Added 1.17%	1,470,704 Common Stock
Dec 04 2023	BUY Grant, award, or other acquisition	-	1,453,279 Added 50.0%	1,453,279 Common Stock

Also insider at

BFLY

Butterfly Network, Inc. Healthcare

President and CEO